Table 1.

Clinical characteristics of the 860 patients (915 samples) with metastatic or recurrent lung adenocarcinoma profiled by MSK-IMPACT

CharacteristicsN = 860 (%)Samples (n = 915)
Age
 18–50122 (14.2)134
 51–75615 (71.5)652
 >75123 (14.3)129
Sex
 Men354 (41.2)369
 Women506 (58.8)546
Smoking status
 Never277 (32.2)302
 Former light (≤15 pack year)153 (17.8)167
 Former heavy (>15 pack year)420 (48.8)436
 Current heavy10 (1.2)10
Sites of tissue for MSK-IMPACT
 Lung420
 Lymph node169
 Pleura/pleural fluid110
 Other81a
 Liver59
 Brain47
 Bone29
  • aOther: Soft tissue, n = 36 (chest wall mass, n = 11; epidural tumor, n = 7; gluteal mass, n = 1; groin, n = 1; iliac mass, n = 1; ischiorectal mass, n = 1; L2 soft-tissue mass, n = 1; L5 soft-tissue mass, n = 1; pararenal mass, n = 1; paraspinal mass, n = 3; paratracheal mass, n = 1; soft-tissue mass scapula, n = 2; pelvic mass, n = 2; T1 soft-tissue mass, n = 1; T12 soft-tissue mass, n = 1; retroperitoneum, n = 1), adrenal, n = 16; skin/subcutaneous nodule, n = 12; pericardium/pericardial fluid, n = 6; ascites/omentum, n = 4; pancreas, n = 2; breast, n = 1; colon, n = 1; spleen, n = 1; uterus, n = 1; diaphragm, n = 1.